Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer

NCT02370277 ·Status: COMPLETED

Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

NCT05417867 ·Status: RECRUITING

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

NCT05910710 ·Status: RECRUITING

Metabolomics and Breast Cancer Risk in a Nested Case-control Study of the Cancer Prevention Study-II Nutrition Cohort

NCT03282812 ·Status: COMPLETED

Tumor Integrating Gut Microbiota in bREast Cancer

NCT07253168 ·Status: NOT_YET_RECRUITING ·Phase: NA

Triple-negative Breast Cancer: a New Perspective on Biomarkers

NCT03539965 ·Status: COMPLETED

Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer

NCT03702868 ·Status: TERMINATED

Breast Cancer and Its Relationship With the Microbiota

NCT03885648 ·Status: ACTIVE_NOT_RECRUITING

BRCA and NACT in TNBC Patients

NCT05750719 ·Status: COMPLETED

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

NCT05877859 ·Status: RECRUITING

A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors

NCT06171360 ·Status: RECRUITING

Tracking Triple-negative Breast Cancer Evolution Through Therapy

NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Comparison of the Breast Tumor Microenvironment

NCT03165487 ·Status: ACTIVE_NOT_RECRUITING

Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC

NCT07290153 ·Status: RECRUITING

Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer

NCT06169007 ·Status: NOT_YET_RECRUITING

Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression

NCT06938373 ·Status: RECRUITING

Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy

NCT00580086 ·Status: COMPLETED

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT03381092 ·Status: UNKNOWN

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

NCT05326295 ·Status: RECRUITING

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

NCT03568448 ·Status: ACTIVE_NOT_RECRUITING

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING

Triple Negative Breast Cancer Biomarker Study

NCT01111175 ·Status: COMPLETED

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

NCT03709134 ·Status: COMPLETED

Screening of Bone Mineral Density in Women Who Have Received Chemotherapy

NCT00603551 ·Status: COMPLETED

LAG3 Expression in Triple Negative Breast Cancer

NCT06259162 ·Status: RECRUITING ·Phase: NA